Cargando…
Emerging degrader technologies engaging lysosomal pathways
Targeted protein degradation (TPD) provides unprecedented opportunities for drug discovery. While the proteolysis-targeting chimera (PROTAC) technology has already entered clinical trials and changed the landscape of small-molecule drugs, new degrader technologies harnessing alternative degradation...
Autores principales: | Ding, Yu, Xing, Dong, Fei, Yiyan, Lu, Boxun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620493/ https://www.ncbi.nlm.nih.gov/pubmed/36218065 http://dx.doi.org/10.1039/d2cs00624c |
Ejemplares similares
-
Emerging New Concepts of Degrader Technologies
por: Ding, Yu, et al.
Publicado: (2020) -
Targeting mitochondrial degradation by chimeric autophagy-tethering compounds
por: Liu, Zhenqi, et al.
Publicado: (2023) -
Emerging Role of the Autophagy/Lysosomal Degradative Pathway in Neurodevelopmental Disorders With Epilepsy
por: Fassio, Anna, et al.
Publicado: (2020) -
Lysosome: regulator of lipid degradation pathways
por: Settembre, Carmine, et al.
Publicado: (2014) -
Public engagement pathways for emerging GM insect technologies
por: Burgess, Michael M., et al.
Publicado: (2018)